TCT
AZN icon

TIAA CREF Trust’s AstraZeneca AZN Stock Holding History

TIAA CREF Trust’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		$544K Buy
+8,730
New +$508K ﹤0.01% 327
2016
Q1 		– Sell
-5,291
Closed -$359K – 328
2015
Q4 		$359K Buy
5,291
+103
+2% +$6.75K ﹤0.01% 310
2015
Q3 		$331K Buy
+5,188
New +$341K ﹤0.01% 306

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

TIAA CREF Trust's AZN Position: Q1 2017 in Review

TIAA CREF Trust opened a new position in AstraZeneca (AZN) in Q1 2017: 8,730 shares worth $544K. The stake represents ﹤0.01% of the portfolio and ranks #327 among its holdings. This is a return to the name: TIAA CREF Trust previously reported a position in AZN as recently as Q4 2015.

TIAA CREF Trust first reported a position in AZN in Q3 2015 and has held it in 3 quarters since. 460 funds tracked by Wall St. Rank hold AZN as of Q1 2017.

  • TIAA CREF Trust held 8,730 shares of AstraZeneca worth $544K as of Q1 2017.
  • AstraZeneca was a new TIAA CREF Trust position in Q1 2017.
  • AstraZeneca made up ﹤0.01% of TIAA CREF Trust's portfolio in Q1 2017, its #327 holding.
  • TIAA CREF Trust first reported a position in AstraZeneca in Q3 2015 and has held it in 3 quarters since.
  • 460 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2017.

Based on TIAA CREF Trust's 13F filing for Q1 2017, filed 3 May 2017.